This firm-fixed-price purchase order was awarded by the Food and Drug Administration (FDA), a civilian agency, to Steris Corporation, a foreign-owned, for-profit manufacturer, to provide comprehensive platinum preventive maintenance for a STERIS autoclave. The contract has a ceiling value of $75,203.32 and a performance period from August 30, 2024, to August 31, 2029. This contract is not associated with a set-aside program. Steris Corporation is a global provider of infection prevention and...
This is a firm fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Steris Corporation, a foreign-owned, for-profit manufacturer of sterile processing equipment and services. The contract, valued at $89,235.00, is for a "Hydrogen Peroxide Bio Decontamination Sterilization System" and has a completion date of November 8, 2020. Steris Corporation is the prime contractor and no set-aside designation is mentioned. The company holds an indefinite delivery contract...
This is a firm fixed-price purchase order contract awarded by the U.S. Department of Agriculture's Agricultural Research Service, a civilian agency, to Steris Corporation, a foreign-owned, for-profit manufacturer of goods. The contract is for a service contract to provide autoclaves, with a ceiling value of $57,571.49 and a completion date of September 23, 2024. The contract was awarded on September 6, 2016, and does not have a set-aside designation. Steris Corporation is a global provider of...
This is a firm fixed-price purchase order contract awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency of the U.S. government, to Steris Corporation for annual service and maintenance of two autoclaves. The contract has a ceiling value of $54,849.00 and a performance period through February 28, 2022. Steris Corporation is a global provider of infection prevention and medical equipment services, specializing in sterilization technologies. The contract does not have a...
This is a firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Steris Corporation, a global provider of medical equipment and sterilization services. The contract, valued at $37,080.39, is for STERIS preventive maintenance agreement services. The contract does not have a set-aside designation, indicating Steris competed effectively in the open federal procurement process. The contract award references Steris' expertise in providing medical equipment,...
This is a firm fixed-price purchase order awarded by the Shared Services Center (a civilian federal agency) to Steris Corporation, a foreign-owned, for-profit manufacturer of medical equipment and consumables. The contract is for the repair and service of autoclaves, which are critical sterilization devices used in healthcare settings. The contract has a ceiling value of $13,028.76 and runs from the award date of March 1, 2024, through September 30, 2024. Steris Corporation is the prime...
The U.S. government agency awarded a Firm Fixed Price (FFP) Purchase Order contract to Steris Corporation, a global provider of infection prevention and procedural products and services, for the supply of Spare Parts for the STERIS Autoclaves Centerwide. The contract has a potential value of $12,288.30 and a completion date of June 30, 2007. Steris Corporation, a foreign-owned, for-profit manufacturer, was selected as the prime contractor for this requirement without the use of a set-aside. This...
This firm fixed-price purchase order contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services, to Steris Corporation, a foreign-owned, for-profit manufacturer of medical equipment and services. The $3,228.88 contract is for an autoclave service agreement to provide other functions. The contract has no set-aside designation and runs from the award date of October 22, 2014 through the ultimate completion date...
This federal contract award is for AUTOCLAVE MAINTENANCE services provided by Steris Corporation, a global provider of infection prevention and medical equipment solutions. The $12,200.78 firm fixed-price purchase order was awarded on September 15, 2025, with an ultimate completion date of September 14, 2026. The funding agency is the Central Program Planning Coordination and Support, a civilian agency. The contract is not designated as a set-aside. Steris Corporation, headquartered in Mentor,...
This is a firm-fixed-price purchase order contract awarded by the National Cancer Institute (NCI), a civilian agency, to Steris Corporation, a foreign-owned, for-profit manufacturer of goods. The contract is for the renewal of a service contract to maintain two autoclaves, with a ceiling value of $13,226.78 and a completion date of January 3, 2025. Steris Corporation is the prime contractor and there is no set-aside designation noted. The contract appears to be part of a larger indefinite...